Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2). (2019)
Attributed to:
Identifying the prevalence of antibodies to neuronal membrane targets in first episode psychosis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.43344
Publication URI: https://www.repository.cam.ac.uk/handle/1810/296298
Type: Journal Article/Review